Search Results - "Lococo, Filippo"

Circulating Cell-Free DNA in Neuroendocrine Lung Tumors: Preliminary Data from a Prospective Surgical Series.

Authors: Lococo, Filippo De Paolis, Elisa Sassorossi, Carolina et al.

Source: Applied Sciences (2076-3417); Oct2025, Vol. 15 Issue 19, p10766, 10p

Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies.

Authors: Lococo, Filippo De Paolis, Elisa Evangelista, Jessica et al.

Source: International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 17, p9560. 14p.

Implementation of Artificial Intelligence in Personalized Prognostic Assessment of Lung Cancer: A Narrative Review.

Authors: Lococo, Filippo Ghaly, Galal Chiappetta, Marco et al.

Source: Cancers. May2024, Vol. 16 Issue 10, p1832. 18p.

Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.

Authors: Lococo, Filippo Boldrini, Luca Diepriye, Charles-Davies et al.

Source: BMC Cancer. 11/9/2023, Vol. 23 Issue 1, p1-8. 8p.

Rate and Predictors of Unforeseen PN1/PN2-Disease in Surgically Treated cN0 NSCLC-Patients with Primary Tumor > 3 cm: Nationwide Results from Italian VATS-Group Database.

Authors: Lococo, Filippo Nachira, Dania Chiappetta, Marco et al.

Source: Journal of Clinical Medicine. Mar2023, Vol. 12 Issue 6, p2345. 11p.

Does Myasthenia Gravis Affect Long-Term Survival in Thymic Carcinomas? An ESTS Database Analysis.

Authors: Lococo, Filippo Nachira, Dania Chiappetta, Marco et al.

Source: Diagnostics (2075-4418). Jul2022, Vol. 12 Issue 7, pN.PAG-N.PAG. 11p.

Validation of the 9th Edition of the TNM Classification in Patients with NSCLC and Lymph Node Involvement: A Retrospective, Multicentric, Observational Study.

Authors: Sassorossi, Carolina Chiappetta, Marco Lococo, Filippo et al.

Source: Cancers. Feb2026, Vol. 18 Issue 4, p702. 17p.

Photon-Counting Computed Tomography in Thoracic Surgery: A Narrative Review of Current and Future Applications.

Authors: Mangiameli, Giuseppe Brascia, Debora Lococo, Filippo et al.

Source: Cancers. Nov2025, Vol. 17 Issue 22, p3656. 13p.

Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.

Authors: Lococo, Filippo Boldrini, Luca Diepriye, Charles-Davies et al.

Source: BMC Cancer. 11/9/2023, Vol. 23 Issue 1, p1-2. 2p.

Low-Malignant-Potential Adenocarcinoma: A Histological Category with a Significantly Better Prognosis than Other Solid Adenocarcinomas at IA Stage.

Authors: Chiappetta, Marco Cancellieri, Alessandra Lococo, Filippo et al.

Source: Current Oncology. Apr2025, Vol. 32 Issue 4, p217. 11p.

Type of lymphadenectomy does not influence survival in pIa NSCLC patients who underwent VATS lobectomy: Results from the national VATS group database.

Authors: Chiappetta, Marco Lococo, Filippo Sperduti, Isabella et al.

Source: Lung Cancer (01695002). Dec2022, Vol. 174, p104-111. 8p.

Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer.

Authors: Lococo, Filippo Paci, Massimiliano Rapicetta, Cristian et al.

Source: International Journal of Molecular Sciences. Aug2015, Vol. 16 Issue 8, p19612-19630. 19p.

Role of Peripheral Blood Markers for Detecting Response and Predicting Prognosis in Patients with Non-small-cell Lung Cancer Undergoing Neoadjuvant Therapy and Surgery.

Authors: Lococo, Filippo Chiappetta, Marco Evangelista, Jessica et al.

Source: Lung (0341-2040). Jun2022, Vol. 200 Issue 3, p393-400. 8p.

Accuracy of ¹⁸F-FDG in Detecting Stage I Lung Adenocarcinomas According to IASLC/ATS/ERS Classification.

Authors: Lococo, Filippo Guerrera, Francesco Rena, Ottavio et al.

Source: Heart, Lung & Circulation. May2022, Vol. 31 Issue 5, p726-732. 7p.

Hilar Lymphadenectomy Is Associated With Improved Disease‐Free Survival in Pathologically N0 Non‐Small Cell Lung Cancer.

Authors: Chiappetta, Marco Sassorossi, Carolina Lococo, Filippo et al.

Source: World Journal of Surgery. Feb2026, Vol. 50 Issue 2, p404-412. 9p.

Multidisciplinary Decision-Making and Integrated Strategies in Stage III Non-Small Cell Lung Cancer: Exploring Clinical Reasoning in Therapeutic Choices.

Authors: Borghetti, Paolo Vitiello, Fabiana Giaj-Levra, Niccolò et al.

Source: Journal of Clinical Medicine. May2026, Vol. 15 Issue 10, p3752. 14p.

Management of Hemothorax After Blunt Chest Trauma: Results from a Level II Emergency Department.

Authors: Nachira, Dania Napolitano, Antonio Giulio Nocera, Adriana et al.

Source: Journal of Clinical Medicine. Apr2026, Vol. 15 Issue 8, p2814. 14p.

LANTERN-XGB: An Interpretable Multi-Modal Machine Learning for Improving Clinical Decision-Making in Lung Cancer.

Authors: Dalfovo, Davide Sassorossi, Carolina De Paolis, Elisa et al.

Source: International Journal of Molecular Sciences. Apr2026, Vol. 27 Issue 7, p3128. 17p.

External validation of the N descriptor in the proposed tumour–node–metastasis subclassification for lung cancer: the crucial role of histological type, number of resected nodes and adjuvant therapy.

Authors: Chiappetta, Marco Lococo, Filippo Leuzzi, Giovanni et al.

Source: European Journal of Cardio-Thoracic Surgery. Dec2020, Vol. 58 Issue 6, p1236-1244. 9p.

Tumour dimension is a prognostic factor in thymic epithelial tumours: An update analysis from the ESTS thymic database: Tumour dimension in thymic tumours.

Authors: Chiappetta, Marco Lococo, Filippo Sassorossi, Carolina et al.

Source: Lung Cancer (01695002). May2025, Vol. 203, pN.PAG-N.PAG. 1p.